NCT03227549

Brief Summary

Hip replacement surgery is an effective option for treating pain and functional impairment in chronic hip conditions. Various surgical approaches have been developed to expose the hip joint for the procedure, each with advantages and disadvantages. The posterior approach (PA) to total hip replacement is a commonly used exposure method. This approach involves a large incision and requires multiple cuts through muscle and other soft tissues to expose the hip joint. Despite excellent outcomes, the PA is known to have an increased rate of dislocation compared to other exposures. The direct superior (DS) approach has been developed to improve the PA by decreasing the amount of soft tissue injury at the time of surgery and improving postoperative stability. The DS approach involves a much shorter incision and reduces the need to damage as much soft tissues surrounding the hip joint during exposure. Specialized equipment developed for this technique allows the surgeon to place the hip replacement components. The proposed research study is designed to address a deficit in knowledge regarding outcomes on patients who have had a DS approach for total hip arthroplasty. This study will provide much needed insight into the advantages and disadvantages of the DS approach as compared to PA for total hip arthroplasty.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 22, 2017

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 24, 2017

Completed
12 months until next milestone

Study Start

First participant enrolled

July 10, 2018

Completed
7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 10, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

August 21, 2024

Status Verified

August 1, 2024

Enrollment Period

7 years

First QC Date

June 22, 2017

Last Update Submit

August 19, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • EQ-5D patient reported outcome measure

    Health status measure

    2 years

  • Oxford-12 patient reported outcome measure

    Functional outcome measure

    2 years

Secondary Outcomes (1)

  • Length of stay

    0 - 30 days

Study Arms (2)

Direct Superior Approach

EXPERIMENTAL

The intervention being tested is the surgical approach.

Procedure: Direct Superior ApproachDevice: Total Hip Arthroplasty

Posterior Approach

ACTIVE COMPARATOR
Device: Total Hip ArthroplastyProcedure: Posterior Approach

Interventions

Total hip arthroplasty using direct superior approach

Direct Superior Approach

Total Hip Arthroplasty using direct superior or posterior approach

Direct Superior ApproachPosterior Approach

Total Hip Arthroplasty using posterior approach

Posterior Approach

Eligibility Criteria

Age18 Years - 81 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Symptomatic osteoarthritis of the hip indicating surgical intervention
  • Uncemented femoral stem and acetabular cup indicated
  • Patients between the ages of 18 and 80, inclusive.
  • Ability to give informed consent

You may not qualify if:

  • Patients less than 18 years of age, or 81 years of age and older
  • Active or prior infection of the affected hip
  • Morbid obesity (BMI \> 45)
  • Medical condition precluding major surgery
  • Severe osteoporosis or osteopenia
  • Neuromuscular impairment
  • Patients with known or tested-positive allergy to metals
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Capital District Health Authority

Halifax, Nova Scotia, B3H 3A7, Canada

Location

MeSH Terms

Interventions

Arthroplasty, Replacement, Hip

Intervention Hierarchy (Ancestors)

Arthroplasty, ReplacementArthroplastyOrthopedic ProceduresSurgical Procedures, OperativePlastic Surgery ProceduresProsthesis Implantation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized controlled trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 22, 2017

First Posted

July 24, 2017

Study Start

July 10, 2018

Primary Completion

July 10, 2025

Study Completion

December 1, 2025

Last Updated

August 21, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations